MAY 31, 2017 06:00 PM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
WEBINAR: Case Studies: Scaling Cell Therapy Manufacturing
SPONSORED BY: TERUMO BCT
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
5 2 642

Speakers:
  • Senior Cell Processing Specialist, Terumo BCT
    Biography
      Prior to joining the Cell Processing team at Terumo BCT, Dr. Beltzer was the lead scientist for the research and development of Corning® Synthemax®, a synthetic growth surface for the culture of human embryonic stem cells at Corning Life Sciences. He was a co-founder of RETT Corporation and was a key player in the industrialization of several technology platforms, including phage display and yeast two-hybrid. He has more than 20 years of industrial research and development experience in a broad range of disciplines.

    Abstract:

    DATE: May 31, 2017
    TIME: 6:00PM PDT, 9:00AM SGT, 12:00PM AEDT

    Gain insights into T-cell expansion, viral vector production and scaling production of mesenchymal stem cells (MSCs) through the use of a functionally closed, automated, cell culture process.

    Dr. Beltzer (Terumo BCT, CO, U.S.) will present a number of case studies to describe how process development and economic goals were achieved in both industry and academic settings. Results include up to a 500-fold expansion of T-cells in 12 days, 40 percent reduction in cost of goods (COGs) of growing cells for an allogeneic therapy, and automated viral vector production with titers similar to flask-based processes. Particular attention will be directed toward the process changes often needed to meet these goals.

    Who may this interest?
    • Clinicians, researchers, lab technologists and cell therapy industry professionals
    • Cell therapy manufacturing professionals
    • Gene and immunotherapy manufacturing professionals

    Learning Objectives:

    • New results of T-cell expansion using a hollow-fiber bioreactor system
    • Techniques for scaling production of mesenchymal stem cells (MSCs)
    • New approach to viral vector production

    Show Resources
    Loading Comments...